Chargement en cours...
Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
BACKGROUND: The use of adjuvant chemotherapy (ACT) for stage IB lung adenocarcinoma remains controversial. We examined the benefits of ACT in stage IB patients with tumors composed of solid material. METHODS: The records of 309 patients with stage IB lung adenocarcinoma who had undergone complete re...
Enregistré dans:
| Publié dans: | Thorac Cancer |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons Australia, Ltd
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360240/ https://ncbi.nlm.nih.gov/pubmed/30561142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12942 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|